Boxer Capital’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,094,000
| Closed | -$22.5M | – | 67 |
|
|
2023
Q3 | $22.5M | Hold |
1,094,000
| – | – | 1.2% | 29 |
|
|
2023
Q2 | $51.4M | Hold |
1,094,000
| – | – | 2.39% | 14 |
|
|
2023
Q1 | $45.9M | Hold |
1,094,000
| – | – | 2.26% | 12 |
|
|
2022
Q4 | $41.7M | Hold |
1,094,000
| – | – | 2.2% | 14 |
|
|
2022
Q3 | $42.8M | Hold |
1,094,000
| – | – | 2.41% | 11 |
|
|
2022
Q2 | $35.3M | Hold |
1,094,000
| – | – | 2.24% | 18 |
|
|
2022
Q1 | $36.2M | Hold |
1,094,000
| – | – | 1.86% | 17 |
|
|
2021
Q4 | $46.5M | Hold |
1,094,000
| – | – | 1.81% | 16 |
|
|
2021
Q3 | $48.5M | Hold |
1,094,000
| – | – | 1.69% | 14 |
|
|
2021
Q2 | $62.2M | Hold |
1,094,000
| – | – | 2.19% | 9 |
|
|
2021
Q1 | $81.9M | Hold |
1,094,000
| – | – | 2.78% | 6 |
|
|
2020
Q4 | $94.6M | Hold |
1,094,000
| – | – | 3.04% | 8 |
|
|
2020
Q3 | $66.9M | Hold |
1,094,000
| – | – | 2.31% | 10 |
|
|
2020
Q2 | $45.5M | Sell |
1,094,000
-438,510
| -29% | -$18.2M | 2% | 14 |
|
|
2020
Q1 | $44M | Buy |
1,532,510
+1,182,510
| +338% | +$34M | 3% | 10 |
|
|
2019
Q4 | $25.3M | Buy |
+350,000
| New | +$25.3M | 1.43% | 19 |
|